Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Main Inclusion Criteria: * Written informed consent * Good health with the exception of bronchial asthma (for at least 6 months) * FEV1 \> 60% to \< 80% of predicted (if pretreated with inhaled steroids only) * FEV1 \> 60% to ≤ 85% of predicted (if pretreated with inhaled steroids in combination with other asthma controller) Main Exclusion Criteria: * Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids or long-acting beta2-agonists * Chronic obstructive pulmonary disease (COPD), i.e. chronic bronchitis or emphysema, and/or other relevant lung diseases causing alternating impairment in pulmonary function * Current smoking or cessation of smoking within the last 6 months or previous smoking with a smoking history ≥ 10 cigarette pack-years * Use of other drugs not allowed * Pregnancy or intention to become pregnant during the course of the study, breast feeding, or lack of safe contraception in women of childbearing potential